Report overview
Non-Invasive Drug Delivery refers to the different administration forms of various therapeutic drugs that people use in the process of preventing and treating diseases without invasion.
This report aims to provide a comprehensive presentation of the global market for Non-Invasive Drug Delivery Device, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Non-Invasive Drug Delivery Device. This report contains market size and forecasts of Non-Invasive Drug Delivery Device in global, including the following market information:
Global Non-Invasive Drug Delivery Device Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global Non-Invasive Drug Delivery Device Market Sales, 2018-2023, 2024-2030, (K Units)
Global top five Non-Invasive Drug Delivery Device companies in 2022 (%)
The global Non-Invasive Drug Delivery Device market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Liquid-Based Needle-Free Injector Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Non-Invasive Drug Delivery Device include Novartis AG, Inovio Pharmaceuticals, Inc., Medtronic Plc., Tandem Diabetes Care, Inc., Teva Pharmaceutical Industries Ltd., Crossject Medical Technology, Adherium Ltd., Sensirion AG and Diabeloop, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We has surveyed the Non-Invasive Drug Delivery Device manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Non-Invasive Drug Delivery Device Market, by Type, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Non-Invasive Drug Delivery Device Market Segment Percentages, by Type, 2022 (%)
Liquid-Based Needle-Free Injector
Powder-Based Needle-Free Injector
Global Non-Invasive Drug Delivery Device Market, by Application, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Non-Invasive Drug Delivery Device Market Segment Percentages, by Application, 2022 (%)
Diabetes Management
Vaccine Management
Pain Management
Respiratory Management
Others
Global Non-Invasive Drug Delivery Device Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Non-Invasive Drug Delivery Device Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Non-Invasive Drug Delivery Device revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Non-Invasive Drug Delivery Device revenues share in global market, 2022 (%)
Key companies Non-Invasive Drug Delivery Device sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Non-Invasive Drug Delivery Device sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis AG
Inovio Pharmaceuticals, Inc.
Medtronic Plc.
Tandem Diabetes Care, Inc.
Teva Pharmaceutical Industries Ltd.
Crossject Medical Technology
Adherium Ltd.
Sensirion AG
Diabeloop
PharmaJet
PenJet
Portal Instruments
Capsule Technologies
Propeller Health
Outline of Major Chapters:
Chapter 1: Introduces the definition of Non-Invasive Drug Delivery Device, market overview.
Chapter 2: Global Non-Invasive Drug Delivery Device market size in revenue and volume.
Chapter 3: Detailed analysis of Non-Invasive Drug Delivery Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Non-Invasive Drug Delivery Device in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Non-Invasive Drug Delivery Device capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
